LCIIAR: A Potential Drug Target and Biomarker (G100130111)

Target Name: LCIIAR

NCBI ID: G100130111

LCIIAR

Other Name(s): LOC100130111 variant X2 | Uncharacterized LOC100130111, transcript variant X2 | lung cancer immune cell infiltration associated lncRNA

LCIIAR: A Potential Drug Target and Biomarker

The liver is a crucial organ that plays a vital role in the body, responsible for filtering out harmful substances, producing bile to aid in digestion, and storing glucose to supply the body with energy. The liver is also responsible for metabolizing drugs, and many drugs cause damage to the liver if used for an extended period of time. Therefore, protecting the liver health is essential for drug development. One approach to protect liver health is to target drugs that are known to cause harm to the liver, and LCIIAR is one such potential drug target and biomarker.

LCIIAR: The Potential Drug Target

LCIIAR is a gene that encodes a protein known as long chain intercalating RNA. This protein is expressed in the liver and has been shown to play a role in the regulation of cellular processes that are important for liver health. Specifically, LCIIAR has been shown to be involved in the detoxification of harmful substances, such as drugs, and to protect the liver from damage caused by these substances.

LCIIAR has been shown to have a critical role in the detoxification of many drugs, including chemotherapy drugs, which can cause damage to the liver if used for extended periods of time. For example, studies have shown thatLCIIAR helps to reduce the level of damage caused by chemotherapy drugs to the liver, and to protect the liver cells from these drugs.

LCIIAR may also have a role in the regulation of cellular processes that are important for the maintenance of liver health. For example, studies have shown thatLCIIAR helps to protect the liver cells from stress, which can cause damage to the liver if not managed.

LCIIAR: The Potential Biomarker

LCIIAR has also been shown to be a potential biomarker for liver health. This is because studies have shown thatLCIIAR levels are often elevated in individuals who are experiencing liver damage or other health conditions that may be causing liver damage. For example, studies have shown thatLCIIAR levels are often elevated in individuals who are experiencing cirrhosis of the liver, a condition that can cause significant damage to the liver if left untreated.

LCIIAR levels may also be elevated in individuals who are experiencing other health conditions that can cause liver damage, such as viral infections or nonalcoholic steatohepatitis (NASH). These conditions can cause damage to the liver if left untreated, and may be detected by measuring LCIIAR levels.

Conclusion

LCIIAR is a gene that encodes a protein that has been shown to play a critical role in the regulation of cellular processes that are important for liver health. Specifically, LCIIAR has been shown to play a role in the detoxification of harmful substances and in the regulation of cellular processes that are important for the maintenance of liver health. Therefore, LCIIAR may be a promising drug target and biomarker for the development of new treatments for liver disease. Further research is needed to fully understand the role of LCIIAR in liver health and to develop safe and effective treatments for individuals with liver disease.

Protein Name: Lung Cancer Immune Cell Infiltration Associated LncRNA

The "LCIIAR Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about LCIIAR comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets